Advertisement News Archives - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

News

July 1, 2022

Mesh Bio, MultiOmic partner to develop chronic metabolic disease medicines

Digital health start-up Mesh Bio has collaborated with drug discovery company MultiOmic Health to use artificial intelligence (AI) for developing precision medicines and diagnostics for chronic metabolic disease.

Mesh Bio, MultiOmic partner to develop chronic metabolic disease medicines